




Searching News Database: skeletal-related events
HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
HSMN NewsFeed - 31 May 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Additional items found! 1

Members Archive contains
1 additional stories matching:
skeletal-related events
(Password required)
skeletal-related events
(Password required)